Project Grant R01HL162810
Award Date
9/1/24
Completion Date
5/31/28
Dollars Obligated
$1.7M
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
Colorado, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $162,000.00 in funding to Northeastern University to conduct research on understanding the impact of the sociopolitical environment on cardiovascular disease (CVD) preventive care utilization among Black and Latinx immigrant adults. The key objectives of this 5-year project are to: 1) estimate trends and associations between...
This Project Grant award of $727,972.00 from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) is funding a study to understand racial/ethnic disparities in clinician concordance with hypertension treatment guidelines and blood pressure control. The primary objectives are to: 1) evaluate the extent of racial disparity in hypertension treatment based on the 2017 AHA/ACC guidelines in the Southeastern U.S.; 2) investigate patient, provider, clinic, and...
This federal Project Grant award, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), will fund research to evaluate how immigration status contributes to disparities in cardiometabolic health and accelerated epigenetic aging among Hispanic/Latino populations in the United States. The $103,948 award to Emory University will support three research aims: 1) using California Health Interview Survey data to assess...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $815,229 to The University of Texas Southwestern Medical Center to conduct proteomic profiling research to identify biologic mechanisms underlying the disproportionate burden of heart failure and atrial fibrillation in Black Americans. The project leverages data from the Jackson Heart Study to analyze associations between plasma proteins, subclinical and...
This $103,948 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports a study examining the association between discrimination reported during pregnancy and later cardiovascular disease (CVD) risk in mothers. The 2-year study, led by the University of Denver, will assess maternal CVD risk factors such as body mass index, blood pressure, and arterial stiffness at 3-4 years postpartum. The research also explores whether adverse...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) provides $524,390 to the University of Colorado-Denver to study the relationship between sleep health, circadian timing, and cardiometabolic risk in adolescents with type 1 diabetes. The research aims to utilize a combined sleep health and circadian timing intervention as a mechanistic probe to...
The University of California, San Francisco (UCSF) was awarded a $312,198 Project Grant from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310). The grant, which runs from July 15, 2024 to June 30, 2029, will support a research program focused on cardiovascular disease risk reduction in adolescents and young adults with kidney disease. Key objectives include elucidating patterns of cardiovascular risk, understanding...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will fund a series of prospective, multimodal cardiovascular research studies at Stellenbosch University in South Africa. The $1 award will support investigations into the underlying mechanisms of cardiovascular disease (CVD) in people living with HIV, both before and after the initiation of antiretroviral therapy. The research will utilize...
This Cooperative Agreement award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $962,975 to study the molecular and cellular mechanisms underlying the increased cardiovascular disease (CVD) risk in individuals with type 1 diabetes (T1D) compared to type 2 diabetes (T2D) and non-diabetic individuals. The 3-year project, starting on September 18, 2024, aims...
This Project Grant award, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), will fund a $748,647 study to explore the relationship between food insecurity, migration context, and cardiovascular health outcomes among Latino immigrants. The study, led by Rice University, will use a biobehavioral approach to collect longitudinal, mixed-methods data from 450 Latino immigrants to characterize the...